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Abstract
Background: Four cases of paroxysmal kinesigenic dyskinesia (PKD) have been reported in individuals with proximal 16p11.2 microdeletions that include PRRT2.
Case Report: We describe a fifth patient with PKD, features of Asperger’s syndrome, and mild language delays. Sanger sequencing of the PRRT2 gene did not
identify any mutations implicated in PKD. However, microarray-based comparative genomic hybridization (aCGH) detected a 533.9-kb deletion on chromosome 16,
encompassing over 20 genes and transcripts.
Discussion: This case underscores the importance of aCGH testing for individuals with PKD who do not have PRRT2 mutations, particularly when developmental
delays, speech problems, intellectual disability, and/or autism spectrum disorder are present.
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Introduction
Paroxysmal kinesigenic dyskinesia (PKD) is an episodic, brief move-
ment disorder triggered by sudden movements. The phenomenology of
the movements may be dystonic and/or choreic, typically lasting less than
1 minute, and occurring as often as 10–100 times per day. Initial linkage
studies mapped PKD to the pericentromeric region of chromosome 16,1
which supported the 2011 discovery of heterozygous truncating mutations
in the PRRT2 gene (16p11.2) as a highly penetrant cause of familial
PKD.2 Since then, multiple mutations in PRRT2 have been reported
among patients with PKD and other related phenotypes including benign
familial infantile epilepsy (BFIE) and infantile convulsions with choreo-
athetosis (ICCA) syndrome.3 Most of the reported PRRT2 mutations are
nonsense, frameshift, and splice site mutations predicted to result in
truncation of the PRRT2 protein and haploinsufficiency, including the
most common c.629dupC (p.Arg217Profs*8) mutation.3
Microdeletions of chromosome 16p11.2 that include PRRT2 and over
20 neighboring genes have also been implicated as a rare cause of PKD,
with only four patients reported to date.4–7 More commonly, these
proximal 16p11.2 microdeletions have been detected among patients
with variable clinical features including developmental delays, intellectual
disability, minor dysmorphic facial features, and/or autism spectrum
disorder (ASD).8–10 These proximal 16p11.2 microdeletions typically
occur de novo in affected probands; however, recent studies have identified
the aberration in some control subjects and only mildly affected
individuals,11–16 suggesting that this deletion may have incomplete
penetrance and/or variable expressivity. We report a fifth patient with
PKD and a proximal 16p11.2 microdeletion, review the related PKD
cases reported to date, and propose phenotypic clues to facilitate a
diagnosis of PKD in the context of the 16p11.2 microdeletion syndrome.
Case Report
A 12-year-old boy developed his first paroxysmal episode at age 10.5
years. Episodes were triggered by sudden movement after a period of
inactivity such as sitting in a car or watching television on a couch.
During attacks, there was dystonia of both arms and trunk with flexion
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of the left elbow and extension of the right elbow, sometimes back arching,
typically lasting 5–10 seconds (Video 1). The frequency of the episodes was
initially one or two times per month, but subsequently increased to 4–12
times per day without treatment. He did not lose consciousness during the
events, and electroencephalography was unremarkable.
After one of his dystonic episodes, he developed back pain, and
spine imaging revealed grade 2 spondylolisthesis involving the lower
back. No other vertebral abnormality was identified. His history was
also notable for features of Asperger’s syndrome with mild delay in
language milestone acquisition, which prompted speech and occupa-
tional therapies around age 4–5 years. Motor milestones were normal
and there was no history of seizures. He currently attends regular
school. He was treated with carbamazepine, up to 250 mg/day, with
marked improvement in the frequency and severity of the episodes, but
with worsening anxiety. He also had good response to phenytoin but
developed swollen gums. Carbamazepine was reintroduced, up to
200 mg/day with improvement, but he then developed leukopenia
(white blood cell count of 2,800/mL). He could not tolerate
oxcarbazepine, and topiramate was not effective.
Genetic testing included Sanger sequencing of the PRRT2 coding
regions and flanking splice sites, and whole-genome microarray-based
comparative genomic hybridization (aCGH; 180K oligonucleotide +
SNP microarray, Agilent Technologies). Although no pathogenic PRRT2
mutations were detected by sequencing, aCGH identified a 533.9-kb
deletion on chromosome 16 [arr 16p11.2(29564185–30098069)x1;
hg18], encompassing over 20 genes and transcripts and including four
Mendelian disease genes (KIFF22, PRRT2, ALDOA, and TBX6)
(Figure 1). This proximal 16p11.2 deletion was confirmed by fluorescence
in situ hybridization (FISH) using a bacterial artificial chromosome (BAC)
probe that hybridized to 16p11.2 and a control probe that hybridized to
the subtelomere of chromosome 16q (Figure 1). Both parents subse-
quently were tested by aCGH and were negative for the aberration,
indicating that the 16p11.2 microdeletion occurred de novo in the proband.
In addition to the 16p11.2 deletion, aCGH analysis detected a
170.5-kb duplication on chromosome 21 [21q22.11q22.12(34656524–
34827038)x3; hg18], including four genes, two of which are Mendelian
disease genes (KCNE2 and KCNE1). Parental aCGH analysis indicated
that this duplication was paternally inherited, suggesting that it is likely
a benign familial copy number variant (CNV).
Discussion
The PRRT2 gene, located on the short arm of chromosome 16
(16p11.2), encodes the proline-rich transmembrane protein 2.
Although its biological function is presently unknown, murine studies
indicate that it is predominantly expressed in the brain and spinal
cord.2 Heterozygous mutations in PRRT2 were discovered by exome
sequencing in 2011 to be an autosomal dominant cause of familial
PKD.2 The prevalence of PRRT2 mutations in PKD ranges from 20–
65%,17–21 suggesting that other genes and mutations are likely
responsible for PKD in patients without a PRRT2 mutation or
deletion. Since the initial discovery of PRRT2 mutations in PKD, the
phenotypes related to PRRT2 have expanded. For example, PRRT2
mutations have also been identified among patients with BFIE and
ICCA,22,23 indicating that disruption of normal PRRT2 function can
have pleiotropic effects. The majority of PRRT2 mutations associated
with PKD result in protein truncation and haploinsufficiency;3
however, deletion of PRRT2 and neighboring genes at proximal
16p11.2 has also been reported in four cases of PKD.
Patients with the 16p11.2 microdeletion syndrome typically present
with developmental delays, intellectual disability, speech delay, and/or
ASD.8–10 These features are most likely due to haploinsufficiency of
neighboring 16p11.2 genes since PKD patients with truncating PRRT2
mutations have not been reported with these developmental
issues.2,22,23 The recurrent proximal 16p11.2 microdeletion has an
estimated prevalence of two or three in 10,0008,24 and is flanked by
segmental duplications and common CNVs (Figure 1), suggesting that
the rearrangement is most likely mediated by non-allelic homologous
recombination. The reciprocal ,600-kb duplication of proximal
16p11.2 has also been associated with developmental delays, ASD,
and other neurological phenotypes;8,9,25,26 however, this aberration
has significantly reduced penetrance compared to the deletion, given
its frequent inheritance from clinically unaffected parents. Of note,
smaller deletions (,200 kb) at distal 16p11.2, also flanked by
segmental duplications, have been implicated in developmental delay,
childhood obesity, and susceptibility to schizophrenia,27–29 under-
scoring the clinical significance of the 16p11.2 region and the complex
variability in phenotypic expression.
In addition to PRRT2, the identified 533.9-kb deletion also included
the Mendelian disease genes TBX6, KIF22, and ALDOA. These genes
have been implicated in autosomal dominant spondylocostal dysos-
tosis,30 autosomal dominant spondyloepimetaphyseal dysplasia with
joint laxity,31,32 and autosomal recessive glycogen storage disease and
hemolytic anemia,33 respectively. Of note, the autosomal dominant
conditions associated with TBX6 and KIF22 were due to disruption of
the stop codon and missense mutations, respectively, and not from
gene deletions. Our patient does not have any features of hemolytic
anemia or spondylocostal dysostosis. KIF22 missense mutations have
been described in spondyloepimetaphyseal dysplasia patients with
skeletal issues including vertebral endplate irregularities, joint laxity,
scoliosis, and at risk for joint dislocation.31,32 Our patient had grade 2
spondylolisthesis, but there were no other skeletal abnormalities or
joint laxity. As such, it is currently unclear if the heterozygous deletion
of KIF22 in our patient contributed to his spine issue.
A paternally inherited 170.5-kb duplication on chromosome
21q22.11-q22.12 was also detected in the proband. This region has
minimal overlap with CNVs reported among normal individuals in the
Database of Genomic Variants34 and includes the Mendelian disease
genes KCNE1 and KCNE2. Heterozygous missense mutations in
KCNE2 and homozygous mutations in KCNE1 have been associated
with long QT syndrome, and may be pathogenic. Because triplosensi-
tivity to these genes has not been established, this variant was initially
considered to be of uncertain clinical significance; however, detection
of the CNV in a clinically unaffected parent suggested that the
duplication was likely benign.
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Figure 1. Identification of the Proximal 16p11.2 Microdeletion. (A) Microarray-based comparative genomic hybridization (aCGH) results of chromosome 16 in
the proband. The identified 16p11.2 deletion is highlighted in the chromosome view and enlarged. Red, black, and blue dots represent aCGH probes with log2 ratios less
than 20.25, in between 20.25 and 0.25, and greater than 0.25, respectively. (B) Confirmation of the deletion by fluorescence in situ hybridization (FISH) using a BAC
probe that hybridized to 16p11.2 (RP11-114A14) and a control probe that hybridized to the subtelomere of chromosome 16q (16qTEL013). (C) Illustration of the
chromosome 16 ideogram with enlarged views from ,29.2 to 30.3 Mb within cytoband 16p11.2. The location of the 533.9-kb deletion and FISH probe are noted in
relation to the location of known human genes and transcripts from the University of California Santa Cruz (UCSC) Genes track (including gene predictions from
RefSeq, Genbank, Consensus Coding Sequence [CCDS], and UniProt), Online Mendelian Inheritance in Man (OMIM) disease genes (with OMIM identification [ID]
numbers), segmental duplications [color was used to distinguish level of similarity (gray: 90–98% similarity; yellow: 98–99% similarity; orange: .99%], and structural
variants from the Database of Genomic Variants34 (blue bars representing copy number gain copy number variants [CNVs], red bars representing copy number loss
CNVs, and brown bars representing both copy number gain and loss CNVs).
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Table 1. Case Reports of PKD with Proximal 16p11.2 Microdeletions



























































































































This case and the previously reported cases of PKD with 16p11.2
microdeletions are summarized in Table 1. All cases were assessed by
genome-wide copy number analyses, including aCGH and/or single
nucleotide polymorphism (SNP) arrays, and the size of the overlapping
deletions ranged from 432.0 to 895.0 kb. Of the five cases, the age at
onset varied from infancy up to 10.5 years. In addition to PKD, one
patient also had dopa-responsive parkinsonism. Three patients had a
history of infantile convulsions, which is likely attributable to PRRT2
haploinsufficiency since this phenotype is also present in PKD cases
with pathogenic mutations in PRRT2. Consistent with the 16p11.2
microdeletion syndrome, all patients had some developmental delay,
the most common being language delay. Treatment data were
available in two cases, both of which had a very good response to
carbamazepine. Parkinsonism in the first case responded well to low
dose levodopa (200 mg/day). Notably, the paucity of PKD cases
reported with this aberration supports the incomplete penetrance and
variable expressivity previously associated with the relatively common
proximal 16p11.2 microdeletion. The infrequent finding of PKD
among 16p11.2 cases also suggests that deletion of PRRT2 alone may
not always result in a PKD phenotype, and that unknown modifier
genes or other important variables may exist.
The American College of Medical Genetics and Genomics has
recommended chromosomal microarray (CMA) as a first tier
diagnostic test for any patient with developmental delay.35 It has also
been suggested by Dale et al. that CMAs be used as first tier testing in
patients with suspected genetic movement disorders, especially for
those with developmental or intellectual issues.6 Even mild presenta-
tions of developmental delays, speech delays, and/or co-existing ASD
should prompt clinicians to suspect the 16p11.2 microdeletion
syndrome for patients with PKD, as evidenced by our case and those
previously reported. Importantly, sequencing of PRRT2 will not detect
gene deletions, including the recurrent 16p11.2 deletion, and a
negative sequencing result should not dissuade clinicians from the
potential diagnosis of this syndrome for patients with PKD.
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